INTRODUCTION
The omentum, an apron-like structure attached to the greater curvature of the stomach, is made of adipose tissue speckled with islands of a compact tissue containing macrophages, lymphocytes, and hematopoietic cells ('milky spots') (1). It is a highly expandable structure that has the innate ability to sense injured sites in the abdominal cavity and adhere to them. It also reacts to cells and embryonic tissue introduced into the abdominal cavity or inserted directly into the omentum by extending its blood vessels into the implanted tissues. On sensing inert foreign-bodies it rapidly spreads to encapsulate them, as if to protect the internal organs from contact with them. As the omentum becomes activated, the milky spots (rather than the adipose tissue) become reactive and expand. After fusing with the injured tissue, the activated omentum brings about vascularization, debridment, hemostasis, healing, and regeneration of the tissue.
These unique biological properties of the omentum have long been noted and applied in surgical practice. They are due to an exceedingly rich lymphatic supply and a unique cellular composition. In practice, such effects can be delibrately brought about by surgically extending the omentum and suturing to injured tissues in a procedure called omental transposition.
Vascularizing ischemic tissue by omental transposition
For a long time the omentum was thought to have no specific functions and rather to be a nuisance for surgeons. Nonetheless, a few recognized its remarkable ability to facilitate wound healing and prevent infections after surgical procedures. In France, during the first part of the 19th century, Jobert de Lamballe, physician to Louis-Phillipe and later to Napoleon III, noted that the omentum was forming adhesions around injured bowel and postulated that this was preventing the development of peritonitis in soldiers injured in the battlefield. In 1880, the American surgeon Nicholas Senn wrapped the omentum over bowel anastomoses and reported that the procedure strengthened the sutures. In 1908, in recognition of its properties to protect the gut from infections, the British surgeon Morrison called the omentum "great policeman of the abdomen." In Germany in 1926, Knazozovicky successfully detached the omentum and used it for arthroplasty. There followed several reports of using the detached omentum as a piece of autologous tissue to repair vesicovaginal fistulas or as a source of new blood vessels to revascularize areas damaged by ischemia (this historical account has been summarized from refs. 1, 2).
In 1945, Cannady tailored the omentum into a long pedicle by cutting its attachment to the stomach without disrupting its vascular supply. He directed the omentum under the skin and extended it to the site of a severely infected compound fracture of the forearm. The omental graft helped overcome the infection and saved the exposed tendons and nerves, ultimately resulting in a fully functional arm (3) .
In the era before coronary artery bypass graft surgery, omental transposition was used to improve the blood supply to the myocardium. O'Shaughnessy applied an omental pedicle to the pericardium-free myocardium in dogs and later in humans, and demonstrated angiographic evidence of neovascularization of the myocardium as well as relief of anginal pain and improved functional status (4) . Later this procedure was expanded by Knock et al (5) and eventually widely applied in clinical practice by Vineberg et al (6) , who combined omental grafting with implantation of the internal mammary artery. Vineberg later reported improved results and demonstrated angiographically a clear vascular communication between the myocardium, the omental graft, and the adjacent great vessels (6-9).
The omental pedicle was later used extensively by the Romanian surgeon Kirikuta, who applied it to different locations for treating large ischemic defects of infected areas (2) . Beginning in the 1960s, the American neurosurgeon Goldsmith further developed the technique and applied omental transposition in more novel ways by treating traumatic spinal cord injuries and chronic brain disorders (10, 11) .
A site to grow cells in vivo and implant tissue fragments to maintain function
Several investigators have observed that the omentum could serve as a site to grow cells and maintain function of organs extracorporeally. Thus it has long been a standard practice to salvage splenic function, when total splenectomy is required because of traumatic or ischemic damage or for other medical reasons, by implanting small thin pieces (spleen chips) in the omentum. The implanted spleen thrives as blood vessels extend to it from the omentum. Histologically, the spleen chips appear like normal spleen and the splenic function of immunity is preserved (12, 13) .
Another new strategy that is attracting interest is transplanting pancreatic islets to treat type I diabetes. In current practice, islets are injected into the portal vein to implant them in the liver. There is a high failure rate because of a lack of blood supply to these islets, and therefore several injections, at best, are required to make the patient insulin-free (14) . Recent studies in rats in which islets were implanted in an omental pouch have shown 100% recovery from hyperglycemia and normalization of the glucose tolerance test, making the omentum a potentially attractive site to transplant pancreatic islets (15) .
Experimentally, the omentum can also be used as an in vivo cell culture system for tissue engineering. Autologous canine oral epithelial cells and rib chondrocytes, seeded on a porous biodegradable scaffold and implanted into the omentum, proliferated to form multicell layered structures rich in blood vessels, whereas scaffolds cultured in vitro showed only isolated cell growth over scaffolds and a lack of blood vessels (16) . Attempts have also been made to grow hepatocytes on similar 3D scaffolds in order to maximize the number of cells for later transplantation in patients with liver failure. It was found that of the several sites tested, the omentum provided the best in vivo site for hepatocytes to expand maximally over the scaffolds with abundant blood vessels that perfused the 3D structure (17) .
Privileged implantation site for growing embryonic tissue to maturity
In the past five years, several reports have appeared showing that embryonic kidney and pancreas implanted into the fold of the omentum caused maturation of the organ in question. Developed kidneys were structurally normal and able to ultrafilter and make urine to the extent of 10% of normal (18, 19) . Similarly, embryonic pancreas implanted in the omentum also developed functionally, secreted insulin in response to ambient glucose, and reversed hyperglycemia of diabetes (20) . The blood vessels that developed in the mature organ were of host omental origin, whereas the parenchyma was of donor origin (20) . In another set of experiments, Yelick et al used the omentum as a tissue site to successfully mature the embryonic pig tooth structure that consisted of the bonedentin tissue complex (21) . Thus, it appears that the omentum could serve as an in vivo incubator to grow adult organs from embryonic tissue, a remarkable property made possible because of a) the capacity of the omentum to rapidly supply blood to the growing organ and b) the plasticity of the omental blood vessels to adapt to the developing organ (22) .
Angiogenic factors in the omentum
Of the many known water soluble endothelial growth factors that induce angiogenesis, VEGF and bFGF have been most studied. The remarkable ability of the omentum to vascularize injured tissue appears to be due to the high concentration of VEGF and bFGF (also called FGF-2) present in the native omentum and induced to even higher levels when the omentum is activated by injury (23) (24) (25) . Indeed, the omentum was found to contain 10-to 100-fold higher concentration of VEGF than other adult organs (25) . In addition to acting as a mitogen for endothelial cells, VEGF also helps recruit progenitor endothelial cells into the growing blood vessels (26) .
Vineberg et al first showed that omental fat placed in the anterior eye chamber caused neoangiogenesis. By contrast, fat from other sources had no such effects (2). Later, Goldsmith et al demonstrated that a lipid fraction extracted from the omentum, when injected intramuscularly into a wound or a rabbit eye, stimulated angiogenesis (27, 28) . Systemic injection of this fraction also increased blood vessel growth around a severed femoral artery as well as around an experimental bone implant, resulting in improved perfusion, faster healing and stronger bone union (29) . Levy et al showed better neovascularization and regeneration of the transplanted splenic chips after immersion in this lipid fraction and subsequent systemic injections of the lipid (30) . This factor appears to be a unique lipid-soluble angiogenic factor. It has not been purified so far and does not appear to share any similarity to the known vascular endothelial growth factors such as VEGF or bFGF, both of which are water soluble.
Tissue regeneration factors and progenitor cells in the omentum
As the omentum develops from the same tissue as the liver and spleen, it is not surprising that it harbors precursors of lymphocytes, monocytes/macrophages, and to limited extent erythrocytes. Consistent with this, the omentum supports early post-natal hematopoiesis and neutrophilic myelopoiesis, and murine omentum produces early hematopoietic and myelopoietic progenitors (similar to fetal blood cell production) throughout life (31) (32) (33) (34) (35) .
Of the various precursor cells in the omentum, the promacrophages present in milky spots have been studied in greatest detail. Milky spots containing precursors of macrophages expand upon inflammation (32) and are believed to be the source of the peritoneal macrophages that act as the first line of defense against infections of intra-abdominal organs. Also produced in the omentum are specialized growth factors such as granulocyte macrophage colony stimulating factor (GM-CSF), macrophage colony stimulating factor (M-CSF), and granulocyte-colony stimulating factor (G-CSF) which act on the precursor cells to clonally expand the macrophages and possibly other myelopoietic cells (33, 35) .
The omentum also secretes stromal cell derived factor-1α (SDF-1α) (25) . This strong chemotactic factor acts as a ligand for the chemokine receptor-4 (CXCR-4) present on progenitor bone marrow and possibly tissue progenitor cells. SDF-1α is usually not present in adult organs but is expressed in injured organs, where it attracts precursor cells to the injured site to promote healing. As the omentum is constitutively rich in SDF-1α, it could supply this factor to the injured organ after omental transposition to bring about rapid healing.
Proposed mechanism of healing and regeneration by omental transposition
Although the benefits of omental transposition have been known for some time, the mechanisms of its role in healing and regeneration remained poorly understood. With the current new knowledge, one could postulate that upon injury the omentum is activated by sensing blood clots, tissue debris, and infectious agents as "foreign". As the omentum becomes active, it expands towards the injured area and adheres to the injured tissue. Omental transposition would achieve the same purpose of bringing the omentum to the site of injury. Once near the injured site, the activated omentum releases angiogenic and other growth factors that facilitate the growth of new blood and lymphatic vessels which anastamose with those of the injured organ, helping to clear tissue debris and clotted blood, and assuring a fresh blood supply that salvages the tissue from ischemic damage. After anastomosis of the organ vessels with the omental vessels, the injured tissue is supplied with a potent mixture of growth factors (VEGF, bFGF, and others), progenitor cells, and chemotactic factors (like SDF-1α). These factors would promote cell growth and recruit other progenitor cells from the bone marrow and local tissue to finally bring about repair and regeneration.
